Reflexion —> Bankruptcy?

Started by Gfunk6
This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
Get help with your application

Use all the free resources available to you from SDN: articles, guides, expert advising, forums discussions, and school research.

Gfunk6

And to think . . . I hesitated
Moderator Emeritus
Lifetime Donor
20+ Year Member
Advertisement - Members don't see this ad
Looks like RefleXion may basically be done. A Glassdoor post from 8/25, supposedly from their Director of QA, says they laid off almost everyone on 8/21 and are down to ~45 people from >300 a few years ago. Apparently only 12 systems were ever sold, and some of the remaining staff are just dealing with source returns, chillers, and shutdown-type work.

Obviously Glassdoor is anonymous, and I haven’t seen an actual bankruptcy filing yet, but this sounds a lot more like winding the place down than “restructuring.”

Not that surprising. The machine was fascinating technology that solved a problem I was never convinced actually mattered clinically. And requiring repeated FDG injections to make the whole thing work was always a little insane. Very cool engineering. Very questionable clinical value proposition.

RefleXion Medical — Glassdoor review, Aug. 25, 2026
Reviewer identifies themselves as Director of Quality Assurance.

Reports that on Aug. 21, 2026, RefleXion terminated essentially the remaining workforce, leaving approximately 45 employees, down from more than 300 several years ago. The reviewer states that only 12 systems were sold and describes remaining activities as including return of radioactive sources, chillers, and other shutdown-related work. The overall characterization is that the company’s doors are effectively closed.

 
Looks like RefleXion may basically be done. A Glassdoor post from 8/25, supposedly from their Director of QA, says they laid off almost everyone on 8/21 and are down to ~45 people from >300 a few years ago. Apparently only 12 systems were ever sold, and some of the remaining staff are just dealing with source returns, chillers, and shutdown-type work.

Obviously Glassdoor is anonymous, and I haven’t seen an actual bankruptcy filing yet, but this sounds a lot more like winding the place down than “restructuring.”

Not that surprising. The machine was fascinating technology that solved a problem I was never convinced actually mattered clinically. And requiring repeated FDG injections to make the whole thing work was always a little insane. Very cool engineering. Very questionable clinical value proposition.



There’s not going to be a company that survives and successfully propagates Cool New Rad Onc Toy for the remainder of our careers.
 
Advertisement - Members don't see this ad
Looks like RefleXion may basically be done. A Glassdoor post from 8/25, supposedly from their Director of QA, says they laid off almost everyone on 8/21 and are down to ~45 people from >300 a few years ago. Apparently only 12 systems were ever sold, and some of the remaining staff are just dealing with source returns, chillers, and shutdown-type work.

Obviously Glassdoor is anonymous, and I haven’t seen an actual bankruptcy filing yet, but this sounds a lot more like winding the place down than “restructuring.”

Not that surprising. The machine was fascinating technology that solved a problem I was never convinced actually mattered clinically. And requiring repeated FDG injections to make the whole thing work was always a little insane. Very cool engineering. Very questionable clinical value proposition.



Agreed. I heard their pitch. It’s the kind of thing that you can make sound really exciting to someone with minimal understanding of cancer therapy. I’m not at all surprised they were able to get substantial investment to get going. Im even less surprised they had a very hard time actually selling machines. Like you said, it’s not clear what gap this was supposed to fill to justify the expense.
 
There’s not going to be a company that survives and successfully propagates Cool New Rad Onc Toy for the remainder of our careers.
I think you are right. The big push will probably be for cheaper hardware that is more versatile (like China's United Imaging) - though under the current administration it seems the chances of us being able to buy one in the near future is sub-optimal.
 
Last edited:
There’s not going to be a company that survives and successfully propagates Cool New Rad Onc Toy for the remainder of our careers.
I think Proton therapy is a cool new toy and currently see that propagating. There does not seem to be a proton therapy market crash imminent but would love to hear if people are seeing any hard data on this. I think Mevion is the exception to this rule right now due to reimbursement differences. High cost photon infrastructure seem like a bad business decision with current contracting.
 
I think Proton therapy is a cool new toy and currently see that propagating. There does not seem to be a proton therapy market crash imminent but would love to hear if people are seeing any hard data on this. I think Mevion is the exception to this rule right now due to reimbursement differences. High cost photon infrastructure seem like a bad business decision with current contracting.
Protons are older than IMRT. So definitely not new. Proton users say the protons have 1.1 RBE as well so definitely not cool 😉